234
Participants
Start Date
August 26, 2020
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2028
Microfracture
Debridement of cartilage followed by placement of small holes in the effected area to fill the debrided area with marrow and cells.
Microfracture plus placement of Chondro-Gide® ACC
Debridement of cartilage followed by placement of small holes in the effected area to fill the debrided area with marrow and cells, followed by affixing Chondro-Gide® with fibrin glue.
Regio Kliniken GmbH, Pinneberg
Emory Sports Medicine Complex, Johns Creek
Orthopädische Chirurgie München, München
The MORE Foundation, Phoenix
Orthopaedic Foundation, Stamford
Fraser Orthopaedic Institute, New Westminster
University of Calgary, Calgary
Hamilton Health Sciences, Hamilton
St. Joseph's Healthcare Hamilton, Hamilton
Sunnybrook Research Institute (SRI), Toronto
University of Toronto Orthopaedics, Toronto
Gelenkzentrum Mittelrhein GmbH, Mayen
Universitätsklinikum Schleswig Holstein Campus Lübeck, Lübeck
Sportklinik Ravensburg, Ravensburg
University Hospital Regensburg, Regensburg
Lead Sponsor
Geistlich Pharma AG
INDUSTRY